Transgene-mediated enkephalin expression attenuates signs of naloxone-precipitated morphine withdrawal in rats with neuropathic pain.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Behavioural Brain Research

• Publication date

  2009-01-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bbr.2008.08.005PMID 18761380PMCID PMC2607474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal.

  2007cited by this paper
• The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain.

  2006cited by this paper
• Spinal modulation of calcitonin gene‐related peptide by endocannabinoids in the development of opioid physical dependence

  2006cited by this paper
• Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats.

  2006cited by this paper
• Activation of the spinal ERK signaling pathway contributes naloxone‐precipitated withdrawal in morphine‐dependent rats

  2005cited by this paper
• Resting and Evoked Spinal Substance P Release during Chronic Intrathecal Morphine Infusion: Parallels with Tolerance and Dependence

  2005cited by this paper
• Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan

  2004cited by this paper
• Transgene‐mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain

  2003cited by this paper
• Development of HSV-mediated gene transfer for the treatment of chronic pain.

  2003cited by this paper
• Drug addiction.

  2003cited by this paper
• Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone‐precipitated opioid withdrawal

  2003cited by this paper
• The role of spinal neuropeptides and prostaglandins in opioid physical dependence

  2002cited by this paper
• Genetic Dissociation of Opiate Tolerance and Physical Dependence in δ-Opioid Receptor-1 and Preproenkephalin Knock-Out Mice

  2002cited by this paper
• Therapeutic Efficacy in Experimental Polyarthritis of Viral-Driven Enkephalin Overproduction in Sensory Neurons

  2001cited by this paper
• Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion

  2001influential reference
• Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids.

  2001cited by this paper
• Δ9‐tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

  2001cited by this paper
• Cannabinoid Withdrawal Syndrome Is Reduced in Pre-Proenkephalin Knock-Out Mice

  2000cited by this paper
• Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.

  1999cited by this paper
• The selective cholecystokininB receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats.

  1998cited by this paper
• Where is the locus in opioid withdrawal?

  1997cited by this paper
• Drug abuse: hedonic homeostatic dysregulation.

  1997cited by this paper
• The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.

  1997cited by this paper
• Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.

  1995cited by this paper
• Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD‐134,308

  1995cited by this paper
• Quantitative assessment of tactile allodynia in the rat paw.

  1994cited by this paper
• Inhibition of morphine tolerance and dependence by diazepam and its relation to the CNS Met-enkephalin levels.

  1994cited by this paper
• The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.

  1992cited by this paper
• An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat

  1992cited by this paper
• Neurobiology of Opioids

  1991cited by this paper
• Beta-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats.

  1991cited by this paper
• Magnitude of opioid dependence after continuous intrathecal infusion of mu- and delta-selective opioids in the rat.

  1989cited by this paper
• Magnitude of opioid dependence after continuous intrathecal infusion of μ- and δ-selective opioids in the rat

  1989cited by this paper
• Morphine alters preproenkephalin gene expression.

  1988influential reference
• Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent rats.

  1987cited by this paper
• Electrophysiological evidence for a presynaptic mechanism of morphine withdrawal in the neonatal rat spinal cord.

  1986cited by this paper
• Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice.

  1986cited by this paper
• Dorsal root lesions block the expression of morphine withdrawal elicited from the rat spinal cord.

  1985cited by this paper
• Supraspinal and spinal mediation of naloxone-induced morphine withdrawal in rats.

  1985cited by this paper
• Comparison of the effectiveness of different opioid peptides in suppressing heroin withdrawal.

  1984cited by this paper
• Systemic and intracerebroventricular effects of opioid peptides in withdrawn morphine-dependent rhesus monkeys.

  1983cited by this paper
• Spinal antagonism of tolerance and dependence induced by systemically administered morphine.

  1983cited by this paper
• Suppression of withdrawal symptoms by dynorphin in heroin addicts.

  1982cited by this paper
• Clinical trial of met-enkephalin analogue (DAMME, FK 33-824) on heroin abusers.

  1982cited by this paper
• Clinical trial of met-enkephalin analogue (DAMME, FK 33-824) on heroin abusers.

  1982cited by this paper
• Clinical experience and mechanism of acupuncture and electrical stimulation (AES) in the treatment of drug abuse.

  1980cited by this paper
• Efficient analysis of experimental observations.

  1980cited by this paper
• Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions.

  1978influential reference
• Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats

  1973cited by this paper
• Drug addiction.

  1957cited by this paper

• Phospho-CREB Regulation on NMDA Glutamate Receptor 2B and Mitochondrial Calcium Uniporter in the Ventrolateral Periaqueductal Gray Controls Chronic Morphine Withdrawal in Male Rats

  2025cites this paper
• A Guide to Preclinical Models of Zoster-Associated Pain and Postherpetic Neuralgia.

  2021cites this paper
• Viral vector-mediated gene therapy for opioid use disorders.

  2021cites this paper
• The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: A novel possible therapeutic approach for opioid use disorders

  2021cites this paper
• Sirt3 mediated by lentiviral vector in the periaqueductal gray suppresses morphine withdrawal in rats: A preliminary study

  2019cites this paper
• MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in rats

  2017cites this paper
• Injection of Toll-like receptor 4 siRNA into the ventrolateral periaqueductal gray attenuates withdrawal syndrome in morphine-dependent rats.

  2017cites this paper
• IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats

  2017cites this paper
• Local intramuscular injection of a plasmid encoding human proenkepahlin attenuates incision pain in rats.

  2016cites this paper
• Nonviral vector plasmid DNA encoding human proenkephalin gene attenuates inflammatory and neuropathic pain-related behaviors in mice.

  2016cites this paper
• Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodents.

  2015cites this paper
• THE EFFECT OF HYDROALCHOHOLIC EXTRACT OF HYPERICUM SCABRUM ON MORPHINE WITHDRAWAL SYMPTOMS IN ADULT MALE MICE

  2014cites this paper
• ENHANCING PERIPHERAL OPIOID ANALGESIA: DEVELOPMENT OF VIRAL VECTOR AND SMALL PEPTIDE THERAPIES

  2014cites this paper
• In Vivo Regulation of the μ Opioid Receptor: Role of the Endogenous Opioid Agents

  2013cites this paper
• Neurobiology of Disease

  2012cites this paper
• Gene therapy for the treatment of chronic peripheral nervous system pain.

  2012cites this paper
• Biologic Mechanisms of Oral Cancer Pain and Implications for Clinical Therapy

  2012cites this paper
• Differential Gene Expression in the Nucleus Accumbens and Frontal Cortex of Lewis and Fischer 344 Rats Relevant to Drug Addiction

  2011cites this paper
• Modulating Pain in the Periphery: Gene-Based Therapies to Enhance Peripheral Opioid Analgesia

  2011cites this paper
• Antinociceptive potentiation and attenuation of tolerance by intrathecal β-arrestin 2 small interfering RNA in rats.

  2011cites this paper
• The Role of TNFα in the Periaqueductal Gray During Naloxone-Precipitated Morphine Withdrawal in Rats

  2011cites this paper
• Antinociceptive potentiation and attenuation of tolerance by intrathecal b-arrestin 2 small interfering RNA in rats †

  2011cites this paper
• Peripheral opioid analgesia for the treatment of neuropathic pain: Gene mutation to virus mediated gene transfer

  2010cites this paper
• Endogenous enkephalin does not contribute to the cerebral anti-hyperalgesic action of gabapentin

  2010cites this paper
• Endogenous opiates and behavior: 2009.

  2010cites this paper
• Gene therapy for pancreatitis pain

  2009cites this paper